measuregroup/AID1802291

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081442_AID1802291_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081384_AID1802291_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081474_AID1802291_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081477_AID1802291_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081385_AID1802291_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID328081439_AID1802291_PMID_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34972
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Binding Assay from US Patent US9266835: \"Quinoline derivatives useful as CB-1 inverse agonists\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081474 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081385 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081384 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081477 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081442 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328081439
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1802291

Total number of triples: 17.